Altamira Therapeutics Ltd. Key Management Personnel Compensation Shortterm Employee Benefits
Altamira Therapeutics Ltd. (CYTOF) reported Key Management Personnel Compensation Shortterm Employee Benefits of $883.97 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits · last filed 2025-04-30
CHF
| Period end | Key Management Personnel Compensation Shortterm Employee Benefits 12 month |
|---|---|
| 2023-12-31 | 775.39K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 1.17M CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 946.45K CHF 20-F/A · filed 2024-04-22 |
| 2020-12-31 | 570.62K CHF 20-F · filed 2023-05-16 |
| 2019-12-31 | 888.66K CHF 20-F · filed 2022-04-12 |
| 2018-12-31 | 1.20M CHF 20-F · filed 2021-03-31 |
| 2017-12-31 | 1.86M CHF 20-F · filed 2020-04-16 |
| 2016-12-31 | 1.88M CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | 1.63M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Key Management Personnel Compensation Shortterm Employee Benefits 12 month |
|---|---|
| 2024-12-31 | $883.97K 20-F · filed 2025-04-30 |
| 2023-12-31 | $862.98K 20-F · filed 2025-04-30 |
| 2022-12-31 | $1.23M 20-F · filed 2025-04-30 |